Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,149 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-experienced, virologically suppressed patients with HIV-1: subgroup analyses of the phase 3 EMERALD study.
Huhn GD, Eron JJ, Girard PM, Orkin C, Molina JM, DeJesus E, Petrovic R, Luo D, Van Landuyt E, Lathouwers E, Nettles RE, Brown K, Wong EY. Huhn GD, et al. Among authors: luo d. AIDS Res Ther. 2019 Aug 29;16(1):23. doi: 10.1186/s12981-019-0235-1. AIDS Res Ther. 2019. PMID: 31464642 Free PMC article. Clinical Trial.
Pooled resistance analyses of darunavir once-daily regimens and formulations across 10 clinical studies of treatment-naïve and treatment-experienced patients with human immunodeficiency virus-1 infection.
Lathouwers E, Seyedkazemi S, Luo D, Brown K, De Meyer S, Wong EY. Lathouwers E, et al. Among authors: luo d. HIV Res Clin Pract. 2020 Apr-Jun;21(2-3):83-89. doi: 10.1080/25787489.2020.1794439. Epub 2020 Jul 26. HIV Res Clin Pract. 2020. PMID: 32715952 Free article.
Low Incidence and Brief Duration of Gastrointestinal Adverse Events with Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Over 96 Weeks: Post hoc Analyses of AMBER and EMERALD.
Dunn K, Baugh B, Bejou N, Luo D, Campbell J, Seyedkazemi S, Anderson D. Dunn K, et al. Among authors: luo d. J Int Assoc Provid AIDS Care. 2022 Jan-Dec;21:23259582221088202. doi: 10.1177/23259582221088202. J Int Assoc Provid AIDS Care. 2022. PMID: 35466761 Free PMC article. Clinical Trial.
6,149 results